# Tigecycline

## Tygacil inj 50mg

##### 臨採

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | ITYG                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Indications        | Treatment of complicated skin & skin structure infections， complicated intra-abdominal infections & community-acquired pneumonia caused by susceptible microorganisms sensitive to tigecycline.                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | Adult: a single loading dose of 100 mg IV initially， then 50 mg IV q12h over 30-60 minutes for 5-14 days.                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Hypersensitivity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Adverse Effects    | Abdominal pain， abscess， asthenia， back pain， fever， headache， infection， pain; HTN， hypotension， phlebitis; constipation， diarrhea， dyspepsia， nausea， vomiting; anemia， leukocytosis， thrombocythemia; increased alkaline phosphatase/amylase/BUN/lactic dehydrogenase/SGOT/SGPT， bilirubinemia， abnormal healing， hyperglycemia， hypokalemia， hypoproteinemia， peripheral edema; dizziness， insomnia; increased cough， dyspnea， pulmonary physical finding; pruritus， rash， sweating; inj site reactions. |
| Pregnancy          | Human data suggest risk in 2nd and 3 rd trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

